Reactions Weekly

, Volume 1161, Issue 1, pp 5–5 | Cite as

Rosiglitazone CV risk relative to metformin, sulfonylurea

Clinical study
  • 8 Downloads

Keywords

Public Health Diabetes Mellitus Myocardial Infarction Metformin Acute Myocardial Infarction 

REFERENCE

  1. 1.
    McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM.Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiology and Drug Safety 16: 711-725, No. 7, Jul 2007Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations